The Food and Drug Administration has approved ARS Pharmaceuticals’ neffy epinephrine nasal spray for severe allergic reactions. This makes it… Read more »
Author: Jenifer Goodwin and Gwen Smith
Setback for Neffy Epinephrine Spray as FDA Calls for More Study
The U.S. Food and Drug Administration has declined to approve a novel epinephrine nasal spray to treat allergic reactions. Instead,… Read more »
AAAAI News: Dupilumab Remission; Tezepelumab in Severe Asthma; Palforzia Safety
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »